Hepatocellular carcinoma (HCC) is the seventh most common cancer worldwide and the
second leading cause of cancer-related mortality. HCC typically arises within a cirrhotic liver …

Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease
in the Western world. Ongoing research has furthered our understanding of NAFLD, the …

Abstract Non-Alcoholic Fatty Liver Disease (NAFLD), a progressive liver disease that is
closely associated with obesity, type 2 diabetes, hypertension and dyslipidaemia, represents …

Introduction: Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver
disease worldwide and is associated with hepatocellular carcinoma (HCC), the most …

Abstract Non-Alcoholic Fatty Liver Disease (NAFLD) refers to the accumulation of lipid laden
vacuoles in hepatocytes, occurring in the context of visceral adiposity, insulin resistance and …

Nonalcoholic fatty liver disease (NAFLD) is a global public health concern. Its natural history,
the development of nonalcoholic steatohepatitis (NASH) and fibrosis, is highly variable …

NAFLD is the most common cause of chronic liver disease in the United States and Western
Europe. The lack of definitive mechanisms underlying development of NASH among …

Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the
United States and represents an increasingly important etiology of hepatocellular carcinoma …

Nonalcoholic fatty liver disease (NAFLD) is now the most common liver disease in the
United States, with more than 80 million Americans affected. It represents a spectrum of …

Non-alcoholic fatty liver disease (NAFLD) has emerged as the most common liver disorder
worldwide mainly attributed to the epidemic spread of obesity and type 2 diabetes mellitus …